Adiposogenital dystrophy other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 17: Line 17:
* Sodium levels
* Sodium levels
* Blood and urine osmolality
* Blood and urine osmolality
* Molecular testing for DNA methylation to rule out [[Prader-Willi syndrome]]<ref>Driscoll DJ, Miller JL, Schwartz S, Cassidy SB. Prader-Willi Syndrome. 1998 Oct 6 [updated 2017 Dec 14]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Mirzaa GM, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. PMID: 20301505.</ref>


==References==
==References==

Revision as of 05:58, 29 December 2021

Adiposogenital dystrophy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adiposogenital dystrophy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Head X Ray

CT

MRI

Vision Test

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adiposogenital dystrophy other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adiposogenital dystrophy other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adiposogenital dystrophy other diagnostic studies

CDC on Adiposogenital dystrophy other diagnostic studies

Adiposogenital dystrophy other diagnostic studies in the news

Blogs on Adiposogenital dystrophy other diagnostic studies

Directions to Hospitals Treating Adiposogenital dystrophy

Risk calculators and risk factors for Adiposogenital dystrophy other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ogechukwu Hannah Nnabude, MD

Overview

Laboratory tests on blood and urine such as electrolyte tests and hormonal assays are useful in the diagnosis of adiposogenital dystrophy.

Other Diagnostic Findings

Laboratory tests on blood and urine to determine electrolyte levels as well as hormonal assays are important tests that can may be used to diagnose adiposogenital dystrophy. Such tests include[1]:

  • Pituitary hormones (prolactin, thyroid-stimulating hormone, adrenocorticotropic hormone, growth hormone, follicle-stimulating hormone, luteinizing hormone)
  • Thyroid hormones
  • Serum cortisol
  • Serum estrogen
  • Serum testosterone
  • Sodium levels
  • Blood and urine osmolality
  • Molecular testing for DNA methylation to rule out Prader-Willi syndrome[2]

References

  1. Sanchez Jimenez JG, De Jesus O. Hypothalamic Dysfunction. [Updated 2021 Aug 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-
  2. Driscoll DJ, Miller JL, Schwartz S, Cassidy SB. Prader-Willi Syndrome. 1998 Oct 6 [updated 2017 Dec 14]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Mirzaa GM, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. PMID: 20301505.

Template:WH Template:WS